IndraLab

Statements


ATXN3L increases the amount of KLF5. 3 / 3
| 3

reach
"We identified ATXN3L as a candidate KLF5 DUB because knockdown of ATXN3L decreased KLF5 protein levels and inhibited breast cancer cell proliferation."

reach
"As expected, knockdown of ATXN3L dramatically decreased the endogenous KLF5 protein levels in both cell lines."

reach
"As described above, knockdown of ATXN3L decreased the endogenous KLF5 protein levels in both HCC1806 and SUM1315 cell lines."